(Q36429201)

14 August 2017

1 reference

title

Proteomics-driven progress in neurodegeneration research (English)

1 reference

14 August 2017

1 reference

2

Sophia Kossida

1 reference

14 August 2017

Michael Fountoulakis

1

1 reference

14 August 2017

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

27

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

1556-1573

1 reference

The use of proteomics in biomarker discovery in neurodegenerative diseases

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Joseph disease and Huntington disease: protein patterns in fibroblasts and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Decreased anterior cingulate gyrus metabolic rate in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

Proteomics: new perspectives, new biomedical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic approaches in the search for disease biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Role of pharmacoproteomics in the development of personalized medicine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics: current technologies and applications in neurological disorders and toxicology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Application of proteomics technologies in the investigation of the brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic approaches in brain research and neuropharmacology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Analysis of cerebrospinal fluid proteins by electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

How industry is approaching the search for new diagnostic markers and biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Depletion of the high-abundance plasma proteins

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Interpretation of mass spectrometry data for high-throughput proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Probability-based protein identification by searching sequence databases using mass spectrometry data

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Numerical approaches for quantitative analysis of two-dimensional maps: a review of commercial software and home-made systems

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Prefractionation techniques in proteome analysis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Prefractionation techniques in proteome analysis: the mining tools of the third millennium

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Design of protein purification pathways: application to the proteome of Haemophilus influenzae using heparin chromatography

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Limitations of current proteomics technologies

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Current two-dimensional electrophoresis technology for proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Mass spectrometry: a tool for the identification of proteins separated by gels

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of the cell envelope fraction of Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Biomedical informatics for proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Genetic analysis of the mouse brain proteome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of the fetal brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics in brain research: potentials and limitations

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Towards data management of the HUPO Human Brain Proteome Project pilot phase

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Great mood in proteomics: Beijing and the HUPO Human Brain Proteome Project.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Alzheimer's disease: an overview of current and emerging therapeutic strategies

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Immunotherapy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Alzheimer's disease is a synaptic failure

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

10 years of Genomics, chromosome 21, and Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Protein expression in Down syndrome brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Molecular changes in fetal Down syndrome brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Neuroprotective strategies in Parkinson's disease : an update on progress

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Schizophrenia: diverse approaches to a complex disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The synaptic hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Cingulate gyrus volume and metabolism in the schizophrenia spectrum

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Emerging principles of altered neural circuitry in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Neuroproteomics: expression profiling of the brain's proteomes in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Analysis of expression and posttranslational modification of proteins during hypoxia

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of differential protein expression in neuropathic pain and electroacupuncture treatment models

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of protein oxidation in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Identification of oxidized plasma proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics as a Tool for Discovery: Proteins Implicated in Alzheimer's Disease are Highly Expressed in Normal Pancreatic Islets

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Expression of apoptosis related proteins in brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Differential expression of molecular chaperones in brain of patients with Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic profiling and neurodegeneration in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Brain t-complex polypeptide 1 (TCP- 1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Comparative proteome analysis of thalamus in MK-801-treated rats

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Between-gel reproducibility of the human cerebrospinal fluid proteome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

A proteomic approach in the study of an animal model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Altered expression of hypothetical proteins in hippocampus of transgenic mice overexpressing human Cu/Zn-superoxide dismutase 1

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Profiling proteins related to amyloid deposited brain of Tg2576 mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Increased phosphorylation of elongation factor 2 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21)

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Naturally occurring scrapie in Southdown sheep.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The assay development of a molecular marker for transmissible spongiform encephalopathies.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of nitrated proteins in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Expression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Postmortem changes in the level of brain proteins.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Brain alpha-endosulfine is manifold decreased in brains from patients with Alzheimer's disease: a tentative marker and drug target?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Derangement of hypothetical proteins in fetal Down's syndrome brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic identification of a novel protein regulated in CA1 and CA3 hippocampal regions during intermittent hypoxia.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Actin and the agile spine: how and why do dendritic spines dance?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

High-throughput proteomics and protein biomarker discovery in an experimental model of inflammatory hyperalgesia: effects of nimesulide

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic approach to the identification of voltage-dependent anion channel protein isoforms in guinea pig brain synaptosomes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Myelin basic protein in Alzheimer disease neuronal fractions and mammalian neurofilament preparations

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Methods for increasing the resolution of two-dimensional protein electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Phenotyping of apolipoprotein E using immobilized pH gradient gels for one-dimensional and two-dimensional separations

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Two-dimensional database of mouse liver proteins. An update

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Proteomic analysis of the rat liver

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Biotechnology, the brain and the future

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200500738

7 January 2021

Identifiers

DOI

10.1002/ELPS.200500738

1 reference

14 August 2017

1 reference